499 related articles for article (PubMed ID: 23856888)
1. Mucins in pancreatic cancer and its microenvironment.
Kaur S; Kumar S; Momi N; Sasson AR; Batra SK
Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):607-20. PubMed ID: 23856888
[TBL] [Abstract][Full Text] [Related]
2. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.
Moniaux N; Andrianifahanana M; Brand RE; Batra SK
Br J Cancer; 2004 Nov; 91(9):1633-8. PubMed ID: 15494719
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer.
Ganguly K; Shah A; Atri P; Rauth S; Ponnusamy MP; Kumar S; Batra SK
Semin Cancer Biol; 2022 Nov; 86(Pt 2):511-520. PubMed ID: 35346803
[TBL] [Abstract][Full Text] [Related]
5. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
[TBL] [Abstract][Full Text] [Related]
6. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
Wang S; You L; Dai M; Zhao Y
J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
[TBL] [Abstract][Full Text] [Related]
7. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.
Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS
Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964
[TBL] [Abstract][Full Text] [Related]
10. Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer.
Arcangeli A; Crociani O; Bencini L
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130101. PubMed ID: 24493749
[TBL] [Abstract][Full Text] [Related]
11. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
12. Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.
Wu YM; Nowack DD; Omenn GS; Haab BB
J Proteome Res; 2009 Apr; 8(4):1876-86. PubMed ID: 19714813
[TBL] [Abstract][Full Text] [Related]
13. Serological pancreatic tumor markers and the MUC1 apomucin.
Ho JJ; Kim YS
Pancreas; 1994 Nov; 9(6):674-91. PubMed ID: 7846010
[TBL] [Abstract][Full Text] [Related]
14. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-Stromal Interactions in Pancreatic Cancer.
Zhang Y; Crawford HC; Pasca di Magliano M
Annu Rev Physiol; 2019 Feb; 81():211-233. PubMed ID: 30418798
[TBL] [Abstract][Full Text] [Related]
16. Mucin-based targeted pancreatic cancer therapy.
Torres MP; Chakraborty S; Souchek J; Batra SK
Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
[TBL] [Abstract][Full Text] [Related]
17. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications.
Lakshmanan I; Ponnusamy MP; Macha MA; Haridas D; Majhi PD; Kaur S; Jain M; Batra SK; Ganti AK
J Thorac Oncol; 2015 Jan; 10(1):19-27. PubMed ID: 25319180
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment participates in metastasis of pancreatic cancer.
Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
[TBL] [Abstract][Full Text] [Related]
19. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.
Wartenberg M; Centeno I; Haemmig S; Vassella E; Zlobec I; Galván JA; Neuenschwander M; Schlup C; Gloor B; Lugli A; Perren A; Karamitopoulou E
Eur J Cancer; 2016 Sep; 65():80-90. PubMed ID: 27475963
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
